PUBLIC GOODS Recall: Product may contain undeclared soy. - F-0494-2021
United States
TerminatedClass II
- Company
- PUBLIC GOODS
- Product
- PUBLIC GOODS brand HAIR, SKIN, & NAILS Dietary Supplement; 6…
- Recall date
- April 27, 2021
- Terminated
- August 25, 2022
- Source
- FDA
Reason for recall
Product may contain undeclared soy.
- - Recall initiated
- - Reported by source
- - Recall terminated
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| PUBLIC GOODS brand HAIR, SKIN, & NAILS Dietary Supplement; 60 tablets per bottle; Other ingredients: Stearic acid; croscarmellose sodium, magnesium stearate, aqueous film coating (purified water, hydroxypropyl methylcellulose, vegetable glycerin), microcrystalline cellulose. Allergens: Fish (gelatin from cod, Pollack, haddock, hake, cusk, redfish, sole, and/or flounder). | Not published in this source record | 3,733 bottles | Lot#190063 Lot#192505 |
Distribution
- AK
- AL
- AR
- AZ
- CA
- CO
- CT
- DC
- DE
- FL
- GA
- HI
- IA
- ID
- IL
- IN
- KS
- KY
- LA
- MA
- MD
- ME
- MI
- MN
- MO
- MS
- MT
- NC
- ND
- NE
- NH
- NJ
- NM
- NV
- NY
- OH
- OK
- OR
- PA
- RI
- SC
- SD
- TN
- TX
- UT
- VA
- VT
- WA
- WI
- WV & WY
Official source record
- Agency
- FDA
- Dataset
- FDA Food Enforcement (Recalls)
- Recall number
- F-0494-2021
- Event ID
- 87823
- Status
- Terminated
- Classification
- Class II
- Company
- PUBLIC GOODS
- Product description
- PUBLIC GOODS brand HAIR, SKIN, & NAILS Dietary Supplement; 60 tablets per bottle; Other ingredients: Stearic acid; croscarmellose sodium, magnesium stearate, aqueous film coating (purified water, hydroxypropyl methylcellulose, vegetable glycerin), microcrystalline cellulose. Allergens: Fish (gelatin from cod, Pollack, haddock, hake, cusk, redfish, sole, and/or flounder).
- Quantity
- 3,733 bottles
- Reason
- Product may contain undeclared soy.
- Recall initiation date
- April 27, 2021
- Report date
- May 26, 2021
- Classification date
- Not published in this source record
- Termination date
- August 25, 2022
- Distribution pattern
- AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV & WY
- UPC, lot, and code information
- Lot#190063 Lot#192505
- Voluntary or mandated
- Voluntary: Firm initiated
- Initial notification method
- Letter
- Source last updated
- Not tracked separately from the Public Health Trace retrieval date below
- Public Health Trace retrieval date
Responsible company: PUBLIC GOODS
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| Alaska | 1 |
| Alabama | 1 |
| Arkansas | 1 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Delaware | 1 |
| Florida | 1 |
| Georgia | 1 |
| Hawaii | 1 |
| Iowa | 1 |
| Idaho | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Kentucky | 1 |
| Louisiana | 1 |
| Massachusetts | 1 |
| Maryland | 1 |
| Maine | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| Mississippi | 1 |
| Montana | 1 |
| North Carolina | 1 |
| North Dakota | 1 |
| Nebraska | 1 |
| New Hampshire | 1 |
| New Jersey | 1 |
| New Mexico | 1 |
| Nevada | 1 |
| New York | 1 |
| Ohio | 1 |
| Oklahoma | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| Rhode Island | 1 |
| South Carolina | 1 |
| South Dakota | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
| Virginia | 1 |
| Vermont | 1 |
| Washington | 1 |
| Wisconsin | 1 |
| West Virginia | 1 |
| Wyoming | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
Where this information comes from
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information. See FDA Enforcement Reports versus recall announcements for how that database differs from a press-release-style announcement.
New to reading a recall record? See how to read an FDA recall record and what recall statuses mean.
Technical source data
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class II mean?
FDA classifies this recall as Class II. See how to read an FDA recall record (linked above) for what each classification level means.
Is this recall still active?
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the responsible agency's published instructions, linked below -- recall guidance is set by that agency, not by Public Health Trace.
Official guidance and record verification
Public Health Trace does not provide medical advice -- review the linked official source below for current, authoritative information.
How to interpret this historical record
This record is preserved as published by FDA, as of August 25, 2022.
Status as reported: Terminated.
This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.